ViaCord competitors

I am the Chief Executive Officer, President and Chairman of Abiomed, Inc. (NASDAQ: ABMD), the only medical device company focused solely on heart recovery. At Abiomed, we are driven by our four principles: recovering hearts and saving lives, leading in technology and innovation, growing shareholder value and sustaining a winning culture of putting patients first. As a U.S. military veteran, I also serve as Co-Founder and Chairman of the Mentoring Veterans Program (MVPvets), a nonprofit organization committed to helping military veterans network with industry mentors to discover career opportunities in the life sciences industry.

George Lemaitre is a Chairman/CEO at LEMAITRE VASCULAR INC, Manager at Lemaitre Family LLC, and Board Member at VASCUTECH INC and is based in Greater Boston Area. He has worked as Board Member at LEMAITRE VASCULAR INC, Credit Analyst at Connecticut National Bank/Bridgeport CT, and Associate at MCCOWN DE LEEUW & CO. George works or has worked as Board of Directors at LEMAITRE VASCULAR INC, Owner at LEMAITRE VASCULAR INC, and BOARD MEMBER at Stanford Univ Graduate Schl of Bussiness Management. He attended Stanford Graduate School of Business between 1990 and 1992, Phillips Academy Andover between 1978 and 1982, and Stanford University between 1982 and 1986.

Avi Pelossof was appointed Global President of our infectious disease business unit in March 2013, after serving as Vice President of that business from February 2008 to February 2013. Mr. Pelossof joined Alere as Vice President, Blood-Borne Pathogens in January 2007 and served in that role until January 2008. Mr. Pelossof has more than 20 years of experience in diagnostics, global health and international finance, including senior roles at Chembio Diagnostic Systems, a manufacturer of diagnostic tests for infectious diseases, and Citigroup.

As chief executive officer and member of the board of directors, Joe Woody brings 20 years of healthcare leadership and medical technology expertise to Avanos. Under Joe’s leadership, Avanos has successfully executed its transformation into a focused medical devices business, with a clear strategy to achieve category leadership in its core Pain Management and Chronic Care divisions. Avanos is focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. The company is committed to creating the next generation of innovative healthcare solutions, which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.

David Portnoy is a Chairman and Co-CEO at CRYO CELL INTERNATIONAL INC and is based in Miami/Fort Lauderdale Area. He studied at The Wharton School between 1981 and 1984.

Glenn Aldinger FACEP, FAAEM is a Chairman & CEO at Infinity Healthcare Inc and is based in Greater Chicago Area. He studied at The Ohio State University College of Medicine between 1970 and 1973.